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Abstract: The leaf of Lagerstroemia speciosa L. is used as an anti-diabetic herbal remedy in many 
countries. In an attempt to discover mechanisms of action of the L. speciosa extract that stimulate 
glucose uptake, a cell-based radioactive assay of glucose uptake was performed using L8 muscle cells. 
In this study, the methanol fraction of L. speciosa leaves (LSE) contained a high level of phenolic 
compounds and showed strong capability to stimulate glucose uptake in a dose-dependent manner. The 
LSE  stimulation  was  slightly  inhibited  (8.8%)  by  SB203580.  The  inhibitory  effect  (23.6%)  of 
wortmannin on LSE-stimulated glucose uptake was demonstrated, suggesting LSE action on glucose 
transporter translocation. LSE-induced glucose uptake was completely reversed by cycloheximide. In 
addition, an increased amount of total glucose-transporter-1 protein was observed indicating that new 
protein  synthesis  is  necessary  for  elevated  glucose  transport.  LSE  also enhanced  insulin-stimulated 
glucose transport. These results suggest that LSE action may be mediated primarily via the synthesis of 
new transporters and involve both insulin-dependent and independent pathways. 
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Introduction  
 
        Diabetes Type II has become a predominant public health problem with increasing rate of affecting 
people worldwide [1]. About one third of Type II diabetic patients need insulin to reduce their blood 
glucose levels, and some 40% require oral agents for satisfactory blood glucose control. Currently, due  
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to lack of access to essential medicines developed through pharmaceutical research and as a part of 
local culture, a majority of the world’s population still depends on traditional medicine for primary 
health  care  need.  In  addition,  use  of  complementary  and  alternative  medicine  in  the  treatment  of 
diabetes has increased steadily among the general public. In the U.S. alone, a 380% increase in the use 
of herbal supplements from 1990 to 1997 has been reported [2].
 Thus, a provision of safe and effective 
traditional medical therapies could become a vital tool for increasing access to health care.  
        Lagerstroemia speciosa (L.) Pers. (Lythraceae) is a popular medicinal plant in South-East Asia, 
especially the Philippines. A decoction of L. speciosa leaves has been used for treatment of diabetes [3]. 
The  extract  of  L.  speciosa  significantly  lowered blood sugar in Type II diabetic mice and alloxan-
induced diabetic rats [4-6], and stimulated glucose transport in adipocytes and Ehrlich ascites tumour 
cells [7-8]. Studies have shown an anti-obesity activity of extracts from this plant on KK-Ay mice and in 
3T3-L1 cells [7, 9]. The hypoglycemic effect of the active component (corosolic acid) resulted from 
increased  GLUT4  translocation  in  muscle  of  diabetic  mice  [10].  Recently,  more  active  tannins, 
gallotannins and triterpenes were reported to enhance glucose uptake in 3T3-L1 cells [11-14]. It was 
also noted that the magnitude of the effect of L. speciosa extract was much larger than the effect of the 
individual active compound. 
       According to previous reports, glucose transport enhancement activity of the aqueous extract of L. 
speciosa leaves in 3T3-L1 adipocytes involved a rapid response (15-min) [7, 13]. However, no reports 
of the long-term effects or the mechanisms of action of the extract at cellular and molecular levels have 
been published despite the fact that the extract is commercially available [15]. This present study is 
designed to investigate the effects of the methanol fraction of the aqueous extract of L. speciosa leaves 
on  the  glucose  transport  in  muscle  cells,  a  physiological  target  cells  of  insulin,  by  employing  L8 
myotubes as cell model to assay for glucose uptake activities. The mechanisms
 by which the extract 
mediates the glucose transport activity in the presence of specific inhibitors are also investigated. 
 
Materials and Methods   
Materials  
   
         Rat L8 myoblasts were purchased from American Type Culture Collection (Rockville, MD). Cell 
culture media and supplements were acquired from Life Technologies, Inc. (Gaithersburg, MD). Bovine 
insulin,  cytochalasin  B  (CB),  wortmannin  (WM),  SB203580  (SB),  cycloheximide  (CHX),  protease 
inhibitor cocktail, phloretin, -actin antibody, enzyme-linked antibodies and standard chemicals were 
purchased from Sigma Chemicals (St. Louis, MO). 2-Deoxy-D-[
3H] glucose (2-dGlc) was obtained 
from  Amersham  Biosciences  (Piscataway,  NJ).  A  polyclonal antibody against glucose transporter 1 
(GLUT1)  was  purchased  from  Santa  Cruz  Biotechnology,  Inc.  (Santa  Cruz,  CA).  A  monoclonal 
antibody against glucose transporter 4 (GLUT4) was purchased from R&D systems, Inc. (Minneapolis, 
MN). Electrophoresis and protein assay reagents were purchased from Bio-Rad (Hercules, CA). The 
CytoTox 96 non-radioactive cytotoxicity assay kit was purchased from Promega (Madison, WI).  
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Sample preparation 
         Lagerstroemia speciosa  leaves were collected from the medicinal plants garden of the Faculty of 
Pharmaceutical  Sciences,  Prince  of  Songkla  University,  Hat-Yai,  Thailand.  They  were  cleaned  by 
washing with running tap water and rinsing with distilled water, and placed in a 45
OC oven until they 
were completely dried. Five grams of the powdered leaf  sample were extracted with 200 ml water at 
70
OC for 30 min. After filtering, the solution obtained was centrifuged at 5,000 g for 20 min and the 
supernatant concentrated by freeze-drying to give a crude extract. A portion of the crude extract (1.45 
g) was further separated by passage through a Sephadex LH-20 column with methanol as eluent to 
afford 32 fractions (20 ml each). The eluted fractions were subjected to thin-layer chromatographic 
analysis using silica gel 60 F254 plates (0.20 mm thick) with ethyl acetate-chloroform-methanol (2:1:1) 
as developing solvent. Fractions 14-21, which showed similar chemical profiles, containing mainly 4 
tailing phenolic compounds which gave greenish-blue colour upon spraying with 10% ferric chloride in 
absolute ethanol, were pooled and evaporated to give a dried residue of the methanol fraction (LSE: 
986  mg).    Upon  phytochemical  screening  (see  Table  1),  besides  phenolic  compounds  (including 
tannins), triterpenoids and carbohydrates were also detected in LSE. The residue (LSE) dissolved in 
water and sterilised with 0.45-m filters was used for the glucose transport study. 
 
Cell and culture conditions 
         L8 myoblasts were maintained and differentiated as described previously [16]. Briefly, the cells 
were seeded in complete Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum 
at 35,000 cells/cm
2 in 24-well plates for glucose uptake assay and 100-mm plates for protein analysis. 
When cells reached ~95% confluence, differentiation was initiated by culturing them in a medium with 
2% horse serum (HS). In the present experiment, ~80-85% of the myoblasts fused into myotubes. The 
cells were rinsed with HEPES buffered saline, pH 7.4 (HBS). Thereafter, HBS (1x final concentration) 
containing 2% HS, 15 mM glucose and LSE at the desired concentration (0, 20, 40, 80, 100, 120 or 
140 g/ml) or 100 nM insulin were added to the cells, which were then incubated at 37°C for 16 h. In 
order to investigate the effect of insulin, the medium was changed to serum-free HBS (1x) containing 
25 mM glucose, and incubated at 37°C for 5 h before the assay of glucose transport. For the inhibitor 
studies,  2  g/ml  CHX,  100  nM  WM,  10  M  SB  and  40  M  CB  were  added  individually  or  in 
combination to the LSE-treated cells at a respective time (CHX, 16 h; WM, 20 min; SB, 30 min; and 
CB, 30 min) prior to the end of the 16-h incubation. Phloretin (10 mM), an inhibitor of a variety of 
membrane transporters including facilitated glucose transport [17], was added to the incubation mixture 
20 min before the uptake assay to determine the effect of non-specific uptake. Using the CytoTox 96 
non-radioactive  cytotoxicity  assay, an aliquot from each well was taken to determine the cytotoxic 
effect according to the manufacturer’s instructions.  
 
2-dGlc uptake assay  
         The L8 myotubes were rinsed twice with 1 ml HBS. After rinsing, glucose uptake was initiated
 by 
the addition of 0.3 ml of HBS (1x) containing 2-dGlc (1 µCi/ml) without or with 100 nM insulin as the  
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final concentration to the cells.
 After 10 min, the medium was aspirated and the plates were washed
 
three times with ice-cold 0.9% NaCl to terminate the induced glucose uptake. The
 cells were lysed in 
0.05 N NaOH and the radioactivity taken up by the cells
 was determined using a scintillation counter. 
Preliminary studies (data not shown) demonstrated that uptake of 2-dGlc (1 µCi/ml) was linear up to 15 
min. Non-specific uptake measured in the presence of phloretin was less than 10% of the total uptake. 
Aliquots  from  each  treatment  were  used  to  determine  the protein concentration using the Bio-Rad 
protein assay. 
 
Analysis of glucose transporter 
         A method described by Yu et al.
 [18] was used with modification. L8 myotubes grown in 100-mm 
plates and incubated with and without 100 g/ml LSE were washed twice with cold phosphate-buffered 
saline (PBS). The cells were treated with 20 strokes in homogenising buffer (25 mM sucrose, 20 mM 
HEPES, pH 7.4, 2 mM EGTA, 5 mM NaN3, protease inhibitors). Cell lysates were centrifuged at 200 g 
for 5 min. The supernatant (whole cell lysate) was collected for total GLUT1 and GLUT4 protein 
analysis or further centrifuged at 16,000 g for 15 min to pellet the plasma membrane (PM) from the 
supernatant or soluble (S) fraction. Protein samples (150 g) were separated in 10% SDS-PAGE and 
transferred to PVDF for the Western blot analysis. Non-specific sites on the membrane were blocked 
with 5% non-fat dry milk. Antibodies against GLUT1 (1:700), GLUT4 (1:250) or -actin (1:700) were 
added  and  maintained for 2 h at room temperature. Blots were then incubated with enzyme-linked 
second antibody followed by colourimetric or chemiluminescent detection. The immunoreactive protein 
was quantified using scanning densitometry.  
Phytochemical screening and determination of total phenolics 
         Phytochemical  screening  of  LSE  was  performed  using  the  methods  previously  described  by 
Farnsworth [19] and Harborne [20] with slight modification. In brief, several reagents were prepared to 
test  for  the  presence  of  flavonoids,  coumarins,  anthraquinones,  iridoids,  cardiac  glycosides, 
cyanogenetic  glycosides,  coumarins,  saponins,  alkaloids,  tannins,  carbohydrates,  amino  acids  and 
peptides. The results were compared with the positive standards of each test. The amount of total 
phenolic compounds was determined spectrophotometrically using Folin-Ciocalteu reagent as described 
by Lee et al. [21] and was expressed in g of catechin equivalent (CE) based on a calibration curve for 
catechin.  
 
Statistical analyses 
         Three to five separate experiments were conducted in all studies and all assay conditions were 
performed in triplicate. All data are expressed as means  SD. Statistical analyses were performed by a 
one-way  analysis  of  variance  followed  by  Dunnett  t-tests.  The  level  of  P<0.05  was  considered 
significant. 
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Results  
 
LSE-stimulated uptake of 2-dGlc by L8 myotubes in culture 
 
         Figure 1A shows the time course for the uptake of 2-dGlc in L8 myotubes induced by LSE. In 
contrast to previous studies in fat cells [7, 13], the response to LSE in muscle cells was found to be 
slow. The rate of 2-dGlc uptake increased about 1.35, 2.43 and 2.70-fold (P<0.05) of control levels at 
8, 16 and 24 h respectively after exposure to 0.1 mg/ml LSE. The basal uptake activity response to 
prolonged (8-24 h) incubation was lower than that to short-term (0.5-2 h) exposure due to the effect of 
high glucose in the incubation medium [22-23]. When cells were maintained for 16 h with varying doses 
of LSE, a dose-dependent effect was observed (Figure 1B). The maximal uptake activity was achieved 
at 0.1 mg/ml LSE, and thereafter the rate decreased markedly due to the cytotoxic effect. LSE also 
caused a slight toxicity at dose of 0.1 mg/ml. LSE-induced uptake was blocked by cytochalasin B, 
which inhibits cytoskeletal reorganisation when added at 40 M prior to the uptake assay (data not 
shown). This indicates that LSE actively stimulates glucose uptake in the cells and could likely activate 
the movement of glucose across cell membranes. 
                             
 
                                      
Figure 1.   Time  course  and  dose-dependent  effects  of  LSE  on  2-deoxyglucose  uptake.  Panel A:  
L8  myotubes  were  incubated  with  or  without  0.1  mg/ml  LSE  for  the  time  indicated;  Panel  B:  L8 
myotubes were incubated with increasing doses of LSE for 16 h prior to 10-min determination of 2-
deoxyglucose uptake. Data were expressed as means ± SD of the triplicates derived from three separate 
experiments.  
* P<0.05 vs. control cells 
# toxicity observed   
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         Figure 2 shows data from experiments in which the effects of the specific inhibitors on the uptake 
of 2-dGlc were examined in LSE-treated cells. CHX treatment reduced the 2-dGlc uptake rate in the 
control (LSE-untreated) cells by about 55%, indicating that active protein synthesis is necessary for 
maintaining cellular transport of glucose at the basal state. It is clear that CHX could reverse the effect 
of LSE. Approximately 71% reduction of LSE-stimulated 2-dGlc transport by CHX was observed. 
SB203580, which specifically inhibits the activity of p38 mitogen-activated protein kinase (p38 MAPK) 
through  the  interaction  with  its  ATP-binding  domain  resulting  in  the  inactivation  of  glucose 
transporter’s intrinsic activity [24-25], slightly decreased the activity of LSE-induced 2-dGlc uptake 
(8.87  3.69%, n = 5). Wortmannin, which has been shown to interact with the p110 activating subunit 
of phosphatidylinositol 3-kinase (PI3K) resulting in an irreversible inhibition of this kinase that leads to 
inhibition of GLUT4 translocation [26], only partially but significantly reduced the stimulation of LSE 
(23.62  4.90%, n = 5). A higher degree of inhibition was observed when a combination of inhibitors 
was present.  
 
 
 
Figure 2.  Inhibition of LSE-stimulated 2-deoxyglucose uptake activity by SB203580, wortmannin, and 
cycloheximide.  L8  myotubes  were  pre-incubated  with  or  without  0.1  mg/ml  LSE  for  16  h  in  the 
presence of SB203580 (SB), wortmannin (WM), cycloheximide (CHX) or all agents (ALL) as indicated 
prior  to  10  min  determination  of  2-deoxyglucose  uptake.    Inset:  The  reduction  in  glucose  uptake 
activity by inhibitors in LSE-treated cells was recalculated and expressed relative to the uptake activity 
of  LSE  alone.  Data  were  expressed  as  means  ±  SD  of  the  triplicates  derived  from  five  separate 
experiments.  
* P<0.05 vs. values with LSE alone 
 
Figure 3 shows the relationship between insulin and LSE effects on glucose uptake. The cells 
were maintained in serum-free media for 5 h to induce insulin stimulation response before the uptake 
assay was initiated [16, 27]. To enable the detection of additive effect, LSE at a concentration of 80 
µg/ml was used. The activation of glucose transport by insulin was enhanced by 39% in the presence of  
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LSE (for insulin, sugar uptake = 32.37  5.92 pmol/mg protein; for LSE+insulin, sugar uptake = 45.23 
 8.11 pmol/mg protein, n = 5). This indicates a partial additive effect of both agents. 
                                       
Figure 3. Additivity of insulin- and LSE-mediated uptake of 2-deoxyglucose in L8 cells. L8 myotubes 
were stimulated with or without 100 nM insulin and/or 0.08 mg/ml LSE for 16 h and serum-deprived 
for 5 h. Uptake of 2-deoxyglucose was measured over 10 min in the presence or absence of insulin. 
Data were expressed as means ± SD of the triplicates derived from five separate experiments.  
* P <0.05 vs. values with either insulin or LSE alone 
 
         Figure 4 shows the results of a representative experiment: GLUT1 and GLUT4 content in cells 
exposed for 16 h or not exposed to LSE at 0.1 mg/ml. Western blot analyses of GLUT4 content from 
five separate experiments revealed no notable change in the amount of GLUT4 total protein in LSE 
cells (1.11 ± 0.27-fold) compared to that in untreated cells. In contrast, there was an increase in total 
GLUT1 protein content (2.15 ± 0.96-fold) in the LSE-treated cells and the level of GLUT1 protein 
present in the plasma membrane (PM) was much higher than that in the intracellular compartment (S). 
Increased GLUT1 protein content due to LSE was significantly lowered (0.74 ± 0.24-fold, n = 3) to 
below the basal level  when CHX was present (Figure 4C). These results imply that the effect of LSE is 
associated with significant increase in the content of GLUT1 and the magnitude of the gain in uptake 
activity by LSE may be due to enhanced GLUT1 protein synthesis.  
 
Total phenols and active constituents of LSE 
 
         The amount of total phenolics in 1 mg LSE was 409.58  39.57 g catechin equivalent (CE). 
Thus, polyphenols present in the maximal stimulation dose of LSE (0.1 mg/ml) was about 40.9 g CE. 
This implies that increasing glucose transport in L8 muscle cells resulted mainly from the additional 
effect of polyphenols. Table 1 shows the results of phytochemical screening of LSE for the presence of 
active constituents. As evident from the Table, LSE yielded a positive result with Liebermann-Burchard 
test,  indicating  the  presence  of  triterpenoid  compounds.  It  was  also  positive  with  Molisch’s  test, 
suggesting  the  presence  of  free  carbohydrates  and/or  bound  sugars  in  the  form  of  glycosidic 
compounds. Furthermore, LSE gave positive results in reactions with 1% gelatin solution  and 1% ferric 
chloride solution, suggesting the existence of tannins.  
Maejo Int. J. Sci. Technol.  2009, 3(03), 472-485   
 
 
479 
 
                                       
 
Figure 4.  Determination of total GLUT4 and GLUT1 protein content (panel A), GLUT1 localisation 
(panel B), and the inhibitory effect of CHX on total GLUT1 level (panel C) in LSE-stimulated cells. L8 
myotubes  were  treated  with  or  without  0.1  mg/ml  LSE  and  2  g/ml  CHX  for  16  h.  Cells  were 
homogenised, and total lysate, plasma membrane (PM) and intracellular fraction (S) were prepared. 
Samples were Western blotted and probed for GLUT1, GLUT4 and -actin with specific antibodies. 
Immunoblots are representative of 3-8 samples. 
 
 
Discussion 
         Natural  remedies  are  viable  alternatives  to  oral  medications  that  may  cause  undesirable  side 
effects.  Indeed,  many  plants  with  a  glucose-lowering  effect  have  been  used  successfully  for  the 
treatment  of  diabetes.  Particularly,  one  of  the  various  botanical  health  care  products,  L.  speciosa 
extract, has been made available worldwide [28-29]. However, these health care products have not been 
evaluated by the US FDA and have little scientific analyses to confirm the effects and mechanisms of the 
plant extract and the active ingredients.  
         It is well established that the predominant GLUT4 isoform expressed in mature muscle cells and 
adipocytes is primarily responsible for the increase in glucose uptake in response to insulin stimulation 
[30]. 
 Increased exocytosis and decreased endocytosis in the presence of insulin, which cause a shift in 
the steady-state distribution of GLUT4 favouring the plasma membrane, result in increase of the amount 
of GLUT4 at the plasma membrane [31]. The present study has shown that the L. speciosa extract 
(LSE)  is  a  potent  activator  of  glucose  transport  in  L8  muscle  cells.  We  have  demonstrated  that 
prolonged exposure to LSE stimulates glucose transport in the absence of insulin. However, analysis of 
blot density displayed no effect in total GLUT4 protein content. In addition, wortmannin, an inhibitor of 
PI3K,  which  blocks  the  translocation  of  insulin-sensitive  GLUT4  from  its  intracellular  pool  to  the 
plasma  membrane  [32-33],  partially  reversed  the  LSE-induced  2-dGlc  uptake.  The  present  results 
suggest that the translocation of the GLUT4 isoform mediated via insulin-regulated, PI3K-dependent 
signaling is essential for LSE-induced glucose transport.  
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Table 1.  Phytochemical screening results of LSE 
 
Test   LSE  Positive standard 
Coumarins 
    (NaOH paper, UV 365 nm) 
 
(-)
 
Stem bark of Alyxia reinwardtii  
   (+): blue colour under UV light 
Anthraquinones 
    (Borntrager test) 
 
(-) 
Aloe (Aloe barbadensis)  
   (+): pink colour in the alkaline layer 
Iridoids 
    (formation of pseudoindicans) 
 
(-) 
Leaves of Clinacanthus nutans  
   (+): green-blue solution 
Cardiac glycosides 
    Kedde’s reagent test 
 
(-) 
Seed kernel of Thevetia peruviana  
   (+): purple solution 
    Liebermann-Burchard test  (+): red colour  
(triterpenoids) 
   (+): green colour (steroids) 
 
    Keller-Kiliani test  (-)     (+): reddish-brown ring 
Saponins 
    Froth test 
 
(-) 
Fruit of Sapindus rarak  
   (+): honeycomb froth  
          (persisted for at least 30 min) 
    Liebermann-Burchard test  (+): red colour  
(triterpenoids) 
   (+): red colour (triterpenoids) 
Flavonoids 
    (Shinoda’s test) 
 
(-) 
Stem of Derris elliptica  
   (+): pink-red solution 
Tannins 
    Reaction with gelatin solution 
 
(+): precipitate 
Gambir (Uncaria gambir) 
   (+): precipitate 
    Reaction with FeCl3 solution  (+): green-blue solution     (+): green-blue solution 
Alkaloids 
    Mayer’s reagent 
 
(-) 
Stem of Arcangelisia flava  
   (+): precipitate 
    Dragendorff’s reagent  (-)     (+): precipitate 
Carbohydrates 
    (Molisch’s test) 
 
(+): purple ring 
Honey (Apis mellifera)  
   (+): purple ring 
Amino acids and peptides    Soy bean (Glycine max)  
    Biuret test  (-)     (+): violet solution 
    Ninhydrin test  (-)     (+): grayish-blue solution 
Note :  (-)  = negative result 
            (+) = positive result 
 
  
Maejo Int. J. Sci. Technol.  2009, 3(03), 472-485   
 
 
481 
         It was reported by Liu et al [7, 13] that exposure to L. speciosa extract results in rapid activation 
of  glucose  uptake  of  serum-starved  adipocytes.  Employing  serum  deprivation  that  involves  the 
depletion of GLUT1 prior to treatment of adipocyte and muscle cell cultures has been practiced in 
several  studies,  and  this  strategy  allows  the  detection  of  strongly  stimulated  glucose  transport  in 
response to insulin and other stimulators which mediate GLUT4 translocation [17, 27, 34]. In addition, 
insulin, for example, has been shown in these studies to be capable of increasing the rate of glucose 
transport in adipocytes 15- to 20-fold, whereas about a 2-fold increase is achieved in muscle cells. In the 
present  study,  we  have  demonstrated  that  short-term  exposure  to  LSE  does  not  activate  glucose 
transport in L8 cells. One possible reason is that the LSE effect on GLUT4 translocation is small (~23% 
of wortmannin-dependent inhibition), thus the increasing glucose uptake activity resulting from GLUT4 
translocation  is  undetected  under  conditions  in  which  the  basal  uptake  is  not  down-regulated  as 
previously reported by Diedrich [16] and Klip et al. [27]. 
         GLUT1, which is plasma-membrane-localised with a relatively small amount found in intracellular 
membrane  compartments  in  cells  and  tissues  in  the  basal  state  [35],  was  reported  to  mediate  a 
significant  fraction  of  non-insulin-dependent  transport  of  glucose  [30].  GLUT1  gene  expression  is 
regulated by various stimuli including cell stress factors, mitochondria inhibitors, hypoglycemia tumour 
necrosis factor  and prolonged insulin exposure [36-41]. Studies in Clone 9 cells that express GLUT1 
but not GLUT2 or GLUT4 have revealed that GLUT1 activation and translocation are not influenced 
by inhibitors of PI3K and p38 MAPK, which reportedly prevent GLUT4 translocation and/or activation 
by insulin [42], suggesting that GLUT1 expression may be mediated by a different mechanism. A lag 
period of more than 2 h preceding the increase in transport rate by LSE in the present study reflects the 
time  required  for  the  concentration  of  glucose  transporters  to  increase  above  the  threshold  level 
whereby the stimulation of transport can be detected. Our results in L8 cells indicate that exposure to 
LSE increases both the number of GLUT1 at the cell surface and the GLUT1 total protein levels. 
Furthermore,  cycloheximide  blocks  the  activation  of  glucose  uptake  by  LSE  and  diminishes  LSE’s 
effect  on  increasing  GLUT1  protein  level.  These  indicate  that  a  component  of  glucose  transport 
stimulation  associated  with  LSE  action  is  the  number  of  GLUT1  up-regulated  via  GLUT1  protein 
expression. It is known that the mRNA half-life is linked to its translation and its stability also affects 
the rate of change of its abundance following an increase in transcription [43]. At the protein level, the 
half-life of GLUT1 could be increased or decreased by particular stimuli [39, 44]. Further studies on the 
actual  mechanism  by  which  LSE  increases  GLUT1  protein  content  that can be attributed to either 
altered GLUT1 gene expression or post-translation regulation of GLUT1 are necessary. Remarkably, 
cycloheximide interferes with LSE-induced glucose uptake, suggesting that the regulation is dependent 
on translation.  
         The p38 MAPK-dependent pathway has been implied in enhancing the intrinsic activity of GLUT1 
and GLUT4 at the cell surface [24-25]. Inhibition of p38 MAPK with specific inhibitor SB203580 
reduces insulin-induced glucose uptake without an effect on insulin-induced GLUT4 translocation [25]. 
In the present study, SB203580 has a small but significant inhibitory effect on LSE-induced glucose 
uptake, demonstrating that the activation of p38 MAPK is involved in LSE action. We have shown that 
LSE-mediated glucose uptake in L8 cells is apparently associated to the mechanisms by which insulin 
signals glucose transport. A further increase in insulin-stimulated glucose transport by LSE provides  
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evidence that LSE may also target diverse cascades, some of which lead to increased glucose transport. 
It has been reported that muscle contraction and hypoxia or metabolic stress cause a normal glucose 
transport  response  involving  activation  of  5’-AMP-activated  kinase  (AMPK)  in  the insulin-resistant 
skeletal muscles, in which insulin signalling of glucose transport and GLUT4 translocation are impaired 
[45]. Thus, taken together, these data suggest that LSE activates glucose transport in L8 muscle cells 
and involves the synthesis of GLUT1 and the activation of PI3K and p38 MAPK as well as the insulin-
independent signalling, which may operate in tandem with the insulin-dependent pathway. 
         In this present study, a significant amount of phenolic compounds in LSE has also been detected. 
This  is  in  good  agreement  with  a  previous  study  [46]  that  reported  a  high  content  (10.3%)  of 
polyphenols in the leaf extract of L. speciosa. In addition, studies have shown that the most active 
components of L. speciosa leaves are polyphenols. These include ellagitannins (i.e. lagerstroemin, flosin 
B and reginin A) and corosolic acid, which have been shown to activate glucose transport in cell culture 
[8, 11]. Recent reports demonstrated the lowering effect of corosolic acid on postchallenge plasma 
glucose levels in human subjects and established its inhibitory effect on glycogen phosphorylase a [46, 
47]. The antidiabetic activity of the leaf extract (standardised to contain 1% corosolic acid) in human 
has been described [15]. The presence of tannins and triterpenoids in LSE is consistent with recent 
studies,  which  reported  more  tannins  and  triterpenes  in  L.  speciosa  and  their  capacity  to  enhance 
glucose uptake in fat cells [11-13]. Furthermore, the activation of the insulin receptor by lagerstroemin 
(a polyphenol) has also been demonstrated in the Chinese hamster ovary cells [48]. Thus, it is apparent 
that  LSE  contains  several  active  polyphenols  that  may  act  synergistically  or  through  multiple 
mechanisms. 
 
Conclusions   
 
         The present study has established that the extract of L. speciosa exerts a direct up-regulatory 
effect on GLUT1 protein expression and, in part, the GLUT4 translocation, which results in the gain of 
glucose  transporters  at  the  plasma  membrane.  The  mechanisms  of  action  contributing  to  increased 
glucose transport involve both the activation of insulin-dependent and insulin-independent signalling 
pathways.  
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